Biomaterial-dependent blood activation during simulated extracorporeal circulation: A study of heparin-coated and uncoated circuits

Thoracic and Cardiovascular Surgeon

Volumn 45, Issue 6, 1997, Pages 295-301

  Borowiec, J W ^a   Venge, P ^a   Henze, A ^a   Nilsson, B ^a   Stiernstrom H ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Blood activation; Heparin coating; Nitric oxide; Simulated extracorporeal circulation

Indexed keywords

BIOMATERIAL; LIPOCALIN; NITRIC OXIDE;

ARTICLE; BLOOD COMPONENT THERAPY; COMPLEMENT ACTIVATION; ENDOTHELIUM CELL; EXTRACORPOREAL CIRCULATION; HEART SURGERY; HEMODIALYSIS; NONHUMAN; PRIORITY JOURNAL; SIMULATION; SMOOTH MUSCLE FIBER;

EID: 0031472746     PISSN: 01716425     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1013752     Document Type: Article

References (26)

1. Moat NE, Shore DF, Evans TW. Organ dysfunction and cardiopulmonary bypass: the role of complement and complement regulatory proteins. Eur J Cardio-thorac Surg. 1993;7:563-73.
2. Menasche P. The inflammatory response to cardiopulmonary bypass and its impact on postoperative myocardial function. Curr Opin Cardiol. 1995;10:597-604.
3. Venge P, Bergstrand H, Håkansson L. Neutrophils and eosinophils. In: Kelley WN, Harris ED, Ruddy S, Sledge CB, eds. Textbook of Rheumatology. Philadelphia: WB Saunders Company; 1993: 269-85.
4. Faymonville ME, Pincemail J, Duchateau J, et al. Myeloperoxidase and elastaseas markers of leukocyte activation during cardiopulmonary bypass in humans. J Thorac Cardiovasc Surg. 1991;102:309-17.
5. Xu SY, Carlsson M, Engström Å, Garcia R, Peterson CGB, Venge P. Purification and characterization of a human neutrophil lipocalin (HNL) from the secondary granules of human neutrophils. Scand J Clin Lab Invest. 1994;54:365-76.
6. McBride WT, Armstrong MA, Crockard AD, McMurray TJ, Rea JM. Cytokine balance and immunosuppressive changes at cardiac surgery: contrasting response between patients and isolated CPB circuits. Br J Anaesth. 1995;75:724-33.
7. Hennein HA, Ebba H, Rodriguez JL, et al. Relationship of the proinflammatory cytokines to myocardial ischemia and dysfunction after uncomplicated coronary revascularization. J Thorac Cardiovasc Surg. 1994;108:626-35.
8. Davies SW, Duffy JP, Wickens DG, et al. Time course of free activity during coronary artery operations with cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1993;105: 979-87.
9. Prasad K, Kalra J, Bharadwaj B, Chaudhary AK. Increased oxygen free radical activity in patients on cardiopulmonary bypass undergoing aortocoronary bypass surgery. Am Heart J. 1992;123:37-45.
10. Fullerton DA, McIntyre RC. Inhaled nitric oxide: therapeutic applications in cardiothoracic surgery. Ann Thorac Surg. 1996;61:1856-64.
11. Fukuhara K, Murakami A, Watanabe G, Kotoh K, Misaki T. Inhaled nitric oxide after lung ischemia reperfusion: effect on hemodynamics and oxygen free radical scavenger system. Eur J Cardiothorac Surg. 1997;11:343-9.
12. Mellgren K, Friberg LG, Mellgren G, Hedner T, Wennmalm A, Wadenwik H. Nitric oxide in the oxygenator sweep gas reduces platelet activation during experimental perfusion. Ann Thorac Surg. 1996;61:1194-8.
13. Ruvolo G, Speziale G, Greco E, Tritapepe L, Mollace V, Nistico G, Marino B. Nitric oxide release during hypothermic versus normothermic cardiopulmonary bypass. Eur J Cardio-thorac Surg. 1995;9:651-4.
14. Worrall NK, Misko TP, Sullivan PM, Hui JJ, Ferguson TB. Inhibition of inducible nitric oxide synthase attenuates established acute cardiac allograft rejection. Ann Thorac Surg. 1996;62:378-85.
15. Eppinger MJ, Ward PA, Jones ML, Bolling SF, Deeb GM. Disparate effects of nitric oxide on lung ischemia-reperfusion injury. Ann Thorac Surg. 1995;60:1169-76.
16. Borowiec J, Hagman L, Tötterman T, Pekna M, Venge P, Thelin S. Circulating cytokines and granulocyte derived enzymes during complex heart surgery - clinical study with special reference to heparin-coating of cardiopulmonary bypass circuits. Scand J Thor Cardiovasc Surg. 1995;29:167-74.
17. Bozdayi M, Borowiec J, Nilsson L, Venge P, Thelin S, Hansson H-E. Effects of heparin-coating of cardiopulmonary bypass circuits on in vitro oxygen free radicals production during coronary bypass surgery. Artif Organs. 1996;20:1008-16.
18. Övrum E, Mollness TE, Fosse E, et al. Complement and granulocyte activation in two different types of heparinized extracorporeal circuits. J Thorac Cardiovasc Surg. 1995;110:1623-32.
19. Pekna M, Borowiec J, Fagerhol MK, Venge P, Thelin S. Biocompatibility of heparin-coated circuits used in cardiopulmonary bypass. Scand J Thor Cardiovasc Surg. 1994;28:5-11.
20. Larm O, Larsson R, Olsson P. A new non-thrombogenic surface prepared by selective covalent binding to heparin via a modified reducing terminal residue. Biomater Med Dev Artif Organs. 1983;2:161-3.
21. Xu SY, Peterson CGB, Carlsson M, Venge P. The development of an assay for human neutrophil lipocalin (HNL) - to be used as a specific marker of neutrophil activity in vivo and in vitro. J Immunol Methods. 1994;171:245-52.
22. Borowiec J, Thelin S, Bagge L, Nilsson L, Venge P, Hansson H.-E. Heparin-coated circuits reduce activation of granulocytes during cardiopulmonary bypass - a clinical study. J Thorac Cardiovasc Surg. 1992;104:642-7.
23. Moen O, Högåsen K, Fosse E, et al. Attenuation of changes in leukocyte surface markers and complement activation with heparin-coated cardiopulmonary bypass. Ann Thorac Sug. 1997;63: 105-11.
24. EL Habbal MH, Smith L, Elliot MJ, Strobel S. Effect of heparin anticoagulation on neutrophil adhesion molecules and release of IL8: C3 is not essential. Cardiovasc Research. 1995; 30:676-81.
25. Finn A, Morgan BP, Rebuck N, et al. Effects of inhibition of complement activation using recombinant soluble complement receptor 1 on neutrophil CD11b/CD18 and L-selectin expression and release of interleukin-8 and elastase in simulated cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1996;111:451-9.
26. Steinberg JB, Kapelanski DP, Olson JD, Weiler JM. Cytokine and complement levels in patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1993;106:1008-16.